The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 54 of 100
Back to Result List

Deal Logic Shire / Takeda

  • After a long bidding phase, the Japanese pharma company Takeda is going to take over the Ireland based manufacturer and wholesaler of pharmaceutical products Shire PLC. In the fifth attempt, Takeda offered USD 62 bn. The acquisition will create a leading provider of drugs for the treatment of rare diseases, cancer, blood clotting disorders, neurological disorders, or gastroenterology. With Shire, Takeda would double the size of their pharmaceutical business to about USD 30 bn, making it one of the top ten pharma companies worldwide. The takeover is the second biggest the pharmaceutical industry has seen so far and the largest overseas acquisition by a Japanese company.

Download full text files

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author:Jacqueline Zeiss, Philipp Hess, Johannes Fink
URN:urn:nbn:de:hbz:992-opus4-7659
URL:https://www.whufinancesociety.com/deal-logic
Series (Serial Number):Deal Logic (2019-01-04)
Publisher:WHU Finance Society e. V.
Place of publication:Vallendar
Document Type:Part of Periodical
Language:English
Date of Publication (online):2019/01/04
Date of first Publication:2019/01/04
Publishing Institution:WHU Finance Society e. V.
Release Date:2019/12/11
Tag:Firmenfusion; Shire PLC; Takeda Pharmaceutical Co Ltd
Company merger; Shire PLC; Takeda Pharmaceutical Co Ltd
Volume:2019
Issue:01-04
Page Number:6
Licence (German):Copyright for this publication